Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/14/2008US7435408 Porous particles comprising excipients for deep lung delivery
10/14/2008US7435407 Inhibition of olfactory neurosensory function to treat eating disorders and obesity
10/14/2008CA2497345C Novel quaternary ammonium compounds
10/14/2008CA2494177C Azulene derivatives and salts thereof for use as na+-glucose cotransporter inhibitors
10/14/2008CA2445145C Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
10/14/2008CA2443784C A new method for the preparation of 2-{2-[4-(4-chloro-1,2-diphenylbut-1-enyl)phenoxy]ethoxy}ethanol and its isomers
10/14/2008CA2436925C Crystalline glucosamine sulphate metal salts
10/14/2008CA2419279C Prodrugs to nmda receptor ligands
10/14/2008CA2396151C Method for the antibiotic coating of bodies with interconnecting microcavities as well as coated bodies and their usage
10/14/2008CA2396146C Process for antibiotic coating of elements with interconnecting microcavities, elements thus coated as well as their usage
10/14/2008CA2387727C Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
10/14/2008CA2384331C The use of halofuginone and related compounds for the treatment of urethral stricture by local administration
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2379995C 11.beta.-aryl-17,17-spirothiolane-substituted steroids
10/14/2008CA2378724C L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
10/14/2008CA2376849C Method of inhibiting leakage of drug encapsulated in liposomes
10/14/2008CA2363038C Granulate with high content of l-carnitine or an alkanoyl l-carnitine, particularly suitable for the production of tablets by direct compression
10/14/2008CA2361843C Swallowable tablets with high content of n-acetylcysteine
10/14/2008CA2354576C Pharmaceutical preparation for inhalation of an opioid
10/14/2008CA2339244C Methods of ophthalmic administration
10/14/2008CA2338801C Tin polyoxaalkanecarboxylates and compositions containing them
10/14/2008CA2338680C Medicinal aerosol formulations
10/14/2008CA2338649C New phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
10/14/2008CA2336139C Large porous particles emitted from an inhaler
10/14/2008CA2331395C Fatty acid analogues for the treatment of diabetes
10/14/2008CA2330359C Reduction of postoperative complications of cardiopulmonary bypass (cpb) surgery
10/14/2008CA2318128C Oral liquid compositions
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2288821C Modulation of human mast cell activation
10/14/2008CA2279279C Lipid complexes and liposomes of highly insoluble platinum complexes
10/14/2008CA2275351C Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
10/14/2008CA2266608C Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders
10/14/2008CA2255865C Synthesis of soluble beta-sheet forming peptides
10/14/2008CA2244085C Therapeutic anti-asthma agents containing selenium compounds
10/14/2008CA2238937C Delivery system for localized administration of medicaments to the upper respiratory tract
10/14/2008CA2237529C Vaccine compositions for intranasal administration comprising chitosan and use thereof
10/14/2008CA2190394C Recombinant viruses, preparation and use thereof in gene therapy
10/14/2008CA2171625C Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
10/14/2008CA2168584C A method for sensitization of cancer cells for killer cell mediated lysis
10/10/2008CA2609104A1 Method and device for treating bursitis
10/10/2008CA2585035A1 Composition for enhancing immunity and reducing inflammation related to infections
10/10/2008CA2585034A1 Composition for improving immune system health
10/09/2008WO2008122054A1 S-adenosylmethionine and methylthioadensosine in chemoprevention and treatment of colon polyps and cancer
10/09/2008WO2008122049A2 Methods and compositions for reduction of side effects of therapeutic treatments
10/09/2008WO2008122038A1 Regulating autophagy
10/09/2008WO2008122032A2 Treatment method for mmp-implicated pathologies
10/09/2008WO2008122020A1 Substituted pyrimidines
10/09/2008WO2008121941A1 Prodrugs of triciribine and triciribine phosphate
10/09/2008WO2008121895A1 Bioabsorbable elastomeric polymer networks, cross-linkers and methods of use
10/09/2008WO2008121893A1 Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist
10/09/2008WO2008121882A1 Improved methods of administration of adenosine a1 receptor antagonists
10/09/2008WO2008121860A1 Peripheral opioid receptor antagonists and uses thereof
10/09/2008WO2008121859A1 Methods of using tricyclic compounds in treating sodium channel-mediated diseases or conditions
10/09/2008WO2008121858A1 Small molecule inhibitors for immune modulation
10/09/2008WO2008121850A2 Small-molecule modulators of melanin expression
10/09/2008WO2008121836A1 Compounds and methods for enhancing mhc class ii therapies
10/09/2008WO2008121826A2 Method for the treatment of fabry disease using pharmacological chaperones
10/09/2008WO2008121817A2 Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition
10/09/2008WO2008121816A2 Biodegradable, polymer coverings for breast implants
10/09/2008WO2008121813A2 Modulation of cytokine production
10/09/2008WO2008121811A2 Surfactant lipids, compositions thereof, and uses thereof
10/09/2008WO2008121805A1 Methods and compositions for selectin inhibition
10/09/2008WO2008121800A1 Methods of separation and detection of bazedoxifene acetate in pharmaceutical compositions
10/09/2008WO2008121786A1 Inhibitors of akt activity
10/09/2008WO2008121768A2 Glycan-binding proteins as therapeutic targets for retinal disorders and treatment methods based thereon
10/09/2008WO2008121748A2 Adenosine a2a receptor antagonists
10/09/2008WO2008121742A2 Inhibitors of bruton's tyrosine kinase
10/09/2008WO2008121709A1 Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
10/09/2008WO2008121687A2 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
10/09/2008WO2008121686A1 Sub-type selective azabicycloalkane derivatives
10/09/2008WO2008121685A1 Methods of use for inhibitors of akt activity
10/09/2008WO2008121670A1 Pyrimidine hydrazide compounds as pgds inhibitors
10/09/2008WO2008121665A1 Methods and compositions for intraocular administration to treat ocular conditions
10/09/2008WO2008121604A2 Compositions and methods for inhibiting expression of a gene from the ebola
10/09/2008WO2008121602A1 Chemical compounds
10/09/2008WO2008121592A2 Acetyl coenzyme a carboxylase inhibitors
10/09/2008WO2008121570A1 Compounds and methods for modulating g protein-coupled receptors
10/09/2008WO2008121558A1 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
10/09/2008WO2008121496A1 Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
10/09/2008WO2008121476A1 Biologically active taxane analogs and methods of treatment by oral administration
10/09/2008WO2008121467A2 Combination therapy for treating cancer
10/09/2008WO2008121387A1 Substituted triazine compounds for nerve regeneration
10/09/2008WO2008121386A2 Calcimimetic compounds for use in the treatment of bowel disorders
10/09/2008WO2008121352A2 Crystal forms of (r) -n-methylnaltrexone bromide and uses thereof
10/09/2008WO2008121348A2 Peripheral opioid receptor antagonists and uses thereof
10/09/2008WO2008121333A1 Certain chemical entities, compositions and methods
10/09/2008WO2008121268A1 Combination therapy for the treatment-of lower urinary tract symptoms
10/09/2008WO2008121258A1 Methods of treating metabolic syndrome using dopamine receptor agonists
10/09/2008WO2008121257A1 Substituted pyrido[2,3-d]pyrimidine derivatives as cannabinoid-1 receptor modulators
10/09/2008WO2008121171A1 Adenylyl cyclases as novel targets for antibacterial interventions
10/09/2008WO2008121126A1 Non-peptidic molecules for detecting and treating tumors
10/09/2008WO2008121107A1 Minocycline oral dosage forms for the treatment of acne
10/09/2008WO2008121102A2 Hedgehog signaling pathway antagonist cancer treatment
10/09/2008WO2008121066A1 Novel tricyclic spiropiperidines or spiropyrrolidines and their use as modulators of chemokine receptors
10/09/2008WO2008121065A1 Novel pyrrolidine derivatives as antagonists of the chemokine receptor
10/09/2008WO2008121064A1 New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705
10/09/2008WO2008121063A1 New imidazo[ 4,5-b]pyridine-7-carboxamides 704
10/09/2008WO2008121021A1 Method for extracting secoisolariciresinol and dihydroquercetin from wood
10/09/2008WO2008120992A1 Novel antibiotics
10/09/2008WO2008120967A1 SYNERGIC PHARMACEUTICAL COMPOSITIONS CONSISTING OF A COMBINATION OF A 5 α-REDUCTASE ENZYME INHIBITOR AND A 1 α- ADRENERGIC RECEPTOR ANTAGONIST
1 ... 3047 3048 3049 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 ... 7860